Professor Haber joined the Institute as a staff scientist in 1984. She was appointed Director of the Institute in June 2000 and Executive Director in June 2003. Professor Haber is known for her world-class research into the treatment of neuroblastoma and acute lymphoblastic leukaemia in children.
Professor Haber holds a conjoint appointment as Professor in the Faculty of Medicine at the University of New South Wales. In 2007, Professor Haber was appointed a Member of the Order of Australia for services to science in the field of research into childhood cancer, to scientific education and to the community. In 2008, she was awarded an Honorary Doctorate from the University of New South Wales for her eminent service to the cancer research community. In 2014, Professor Haber was awarded the Cancer Institute NSW’s Premier’s Award for Outstanding Cancer Researcher of the Year, and in 2015 she was appointed an Inaugural Fellow of the Australian Academy of Health and Medical Sciences.
She leads the Zero Childhood Cancer national child cancer personalised medicine program, which is enabling all newly-diagnosed, high-risk childhood cancer patients in Australia, and all children who relapse following treatment, to have their therapy tailored to the specific genetic and biological characteristics of their individual tumour.